Vertex plans to submit a Marketing Authorization Application (MAA) variation in the European Union in the first half of 2017 for children ages 6 through 11 who have two copies of the F508del mutation. This application will be based on data from a Phase 3 efficacy study with a primary endpoint of absolute change in lung clearance index (LCI). These data are expected before the end of 2016. The revised guidance primarily reflecting the slower than anticipated launch in Germany where fewer than 20 percent of the approximately 2,500 eligible patients have initiated treatment to date; and slower than expected refills for ORKAMBI during the summer months of July and August. Today’s approval in people ages 6 through 11 will drive growth in the U.S. in the fourth quarter of 2016. Growth for ORKAMBI in 2017 will be driven both by obtaining reimbursement approvals in key European and other countries and by continued growth among eligible patients ages 6 through 11 in the U.S. For comments and feedback: contact email@example.com Interactive Charts Default Setting Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
For the original version including any supplementary images or video, visit http://www.nasdaq.com/article/vertex-says-fda-approves-orkambi-cuts-2016-orkambi-revenue-guidance-20160928-01098
Don’t neglect taking out a health insurance plan from your employer. The premiums are normally deducted before taxes and that is less expensive than purchasing an individual plan. If your spouse has a group health insurance plan at their place of work, look over both to see which one is the better one to use for yourself.
But it was also the starter button for the $100 million expansion that Safran Landing Systems celebrated this week. The expansion will allow the Walton plant to increase production of new and refurbished carbon brakes to achieve a significant increase in our growth, said Safran CEO Vincent Mascre at the projects groundbreaking Wednesday. It will continue to grow Kentuckys largest export category, which is aerospace parts. The 68,000-square-foot expansion will bring 80 new jobs to Walton, boosting total employment to 380. It is the fifth expansion in Safrans 17-year history in Northern Kentucky, a U.S. headquarters that the Paris-based company established because of its relationship with G.E. interview skills clinicAviation. web linkMascre said the Walton plant has become a global leader in materials handling and cutting-tool innovations, exporting new ideas to other Safran plants in France and Malaysia. You make us look good, Kentucky Governor Matt Bevin told a group of about 100 Safran employees and suppliers at the groundbreaking. We are known for making exceptional products, engineering and manufacturing exceptional products. We are known for this because of folks like you.
For the original version including any supplementary images or video, visit http://www.wcpo.com/news/insider/job-killing-trade-deals-not-in-walton-ky
You may also be interested to read
- have a peek here